NEW - Pefaclot™ UFH
27.03.2019
"Pefaclot™ UFH" to monitor therapy with unfractionated heparin (UFH)
Pentapharm has adapted the proven PiCT® principle to an application for measuring therapy with unfractionated heparin.
The advantages of the new test system "Pefaclot™ UFH" in brief:
- Reduced bleeding risk for patients
- Fewer venipunctures
- Shorter hands on-time in the lab
- Lower cost
We will be happy to send you detailed information material.
We are looking forward to your response!
- Please call us at: +49 6221 868023
- Or send a Fax: +49 6221 8680255
- Or send an E-Mail: info@loxo.de
Are you looking for additional products?
- Please use the search function of our web page
With best regards
Your LOXO - Team
